The number of people taking a vital anti-HIV drug has fallen by almost two-fifths in just one year in the aftermath of ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

Implementation barriers remain largely programmatic, requiring integrated HIV testing, adherence support, STI services, and ...

A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, U.S., ...

Since the start of the HIV epidemic in 1981, over 700,000 Americans have lost their lives to AIDS. Being infected used to be a death sentence. But now, 40 years later, the U.S. is on the precipice of ...

Meeting UNAIDS’ “95/95/95” targets for 2025—95% of people with HIV knowing their status, 95% of those who know their status on treatment, and 95% of people on treatment having a suppressed viral ...

Did you know that there is a medication referred to as the birth control pill for HIV? HIV Pre-Exposure Prophylaxis (PrEP) is a pill that may cause a revolution in HIV prevention. If taken daily, ...

A twice yearly injection that is highly effective in preventing HIV transmission could dramatically reduce infections and save lives — if the people who would most benefit from the drug can obtain it, ...

Gilead and MSD will be filing the data from the Phase III trials of the once-weekly HIV pill to regulatory authorities.

The six-monthly anti-HIV jab, which prevents HIV through sex, is now stocked for free at 360 government clinics in six of South Africa’s provinces. So how does the jab work, how do you know if you ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...